Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value
01:25pm, Wednesday, 31'st Jan 2024
I forecast GLP-1 drugs to become the largest-selling pharmaceutical class, with US sales of $150 billion in 2030. GLP-1 agonists have shown favorable cardiovascular outcomes and beneficial effects on
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024
12:03pm, Wednesday, 31'st Jan 2024
There is a lot of good news to digest from the biotech sector. Not only does it offer lots of strong stocks in January, but it is also expected to grow rapidly.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 31'st Jan 2024
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Norway's giant wealth fund touts possibility of Novo Nordisk, Eli Lilly joining the trillion-dollar club
06:46am, Wednesday, 31'st Jan 2024
Norway's giant wealth fund says Novo Nordisk and Eli Lilly could be on course to become the first health care companies to join the trillion-dollar club.
Stocks: Reasons to go in on Eli Lilly stock, but avoid Tesla
05:04pm, Tuesday, 30'th Jan 2024
The S&P 500's (^GSPC) historic growth story over the past six months cannot and should not be missed by investors. Deciphering which stocks on the S&P 500 to pick for further growth can be daunting.
Is Lilly (LLY) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Tuesday, 30'th Jan 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know
06:46pm, Monday, 29'th Jan 2024
Eli Lilly (LLY) concluded the recent trading session at $645, signifying a +0.9% move from its prior day's close.
Eli Lilly in ‘good dialogue' with Germany on weight-loss drug coverage
11:25am, Monday, 29'th Jan 2024
Eli Lilly & Co (NYSE: LLY) is in the green this morning following a report that it's in talks with Germany to have its weight-loss drug be included in the country's public health coverage.
Better Buy in 2024: The "Magnificent Seven" or the "Terrific 10"?
06:26am, Monday, 29'th Jan 2024
There's lucrative growth in the healthcare segment. The largest financial companies are no longer big banks.
Could Eli Lilly Be a Trillion-Dollar Company by 2030?
08:25am, Saturday, 27'th Jan 2024
Eli Lilly's valuation has soared over the last year given the blockbuster success of treatments such as Mounjaro and Verzenio. The company has other opportunities, including plaque psoriasis and psori
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
03:57pm, Friday, 26'th Jan 2024
After being mostly down over the past three years, the biotech sector rallied hard to end 2023. The SPDR S&P Biotech ETF (NYSEARCA: XBI ) is up 31% in the last three months.
JNJ, LLY: Health Care Earnings To Watch
01:08pm, Friday, 26'th Jan 2024
Eli Lilly (LLY) is up over 80% year-over-year. Lee Brown discusses health care stocks.
El Lilly surpasses Tesla's market size: why has the biotech stock become so attractive?
06:46am, Friday, 26'th Jan 2024
Barely four years ago, El Lilly (NYSE:LLY) was trading at just around $130. Fast forward, the stock trades at a whopping $627, having recently rubbed a new record price above $645.
Eli Lilly's Wegovy rival Mounjaro gets UK green light
04:28am, Friday, 26'th Jan 2024
Mounjaro, Eli Lilly's (NYSE:LLY) rival weightloss drug to Wegovy and Ozempic, is to be made available in the UK after receiving the regulatory green light. The UK Medicines and Healthcare products Re
British regulator clears Lilly's injection pen for weight-loss drug Mounjaro
11:54am, Thursday, 25'th Jan 2024
Britain's drug regulator on Thursday said it approved Eli Lilly's injection pen to administer the drug Mounjaro against obesity and diabetes.
